menu search

CytoDyn Announces President Takes Medical Leave of Absence

CytoDyn Announces President Takes Medical Leave of Absence
Antonio Migliarese assumes interim President roleDr. Melissa Palmer appointed interim Chief Medical OfficerDr. Salah Kivlighn joins CytoDyn as clinical and strategic advisor VANCOUVER, Washington, May 24, 2023 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today […] The post CytoDyn Announces President Takes Medical Leave of Absence appe... Read More
Posted: May 24 2023, 21:05
Author Name: forextv
Views: 101970

Search within

Pages Search Results: